CN101228159A - 卡麦角林溶剂化物以及卡麦角林ⅰ型的制备 - Google Patents
卡麦角林溶剂化物以及卡麦角林ⅰ型的制备 Download PDFInfo
- Publication number
- CN101228159A CN101228159A CNA200680027137XA CN200680027137A CN101228159A CN 101228159 A CN101228159 A CN 101228159A CN A200680027137X A CNA200680027137X A CN A200680027137XA CN 200680027137 A CN200680027137 A CN 200680027137A CN 101228159 A CN101228159 A CN 101228159A
- Authority
- CN
- China
- Prior art keywords
- cabergoline
- solvent
- structural formula
- solvate
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0515430.7A GB0515430D0 (en) | 2005-07-27 | 2005-07-27 | Preparation of cabergoline |
GB0515430.7 | 2005-07-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101228159A true CN101228159A (zh) | 2008-07-23 |
Family
ID=34976701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA200680027137XA Pending CN101228159A (zh) | 2005-07-27 | 2006-07-27 | 卡麦角林溶剂化物以及卡麦角林ⅰ型的制备 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1912984A1 (no) |
JP (1) | JP2009502895A (no) |
CN (1) | CN101228159A (no) |
AU (1) | AU2006273831A1 (no) |
CA (1) | CA2616738A1 (no) |
GB (1) | GB0515430D0 (no) |
IL (1) | IL188598A0 (no) |
NO (1) | NO20080461L (no) |
WO (1) | WO2007012846A1 (no) |
ZA (1) | ZA200801151B (no) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170095507A1 (en) * | 2014-08-17 | 2017-04-06 | Shanxi Zhendong Ante Biopharmaceutical Co., Ltd. | Dispersion preparation containing colloidal bismuth pectin and preparing method therefor |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1925616A1 (en) * | 2006-10-26 | 2008-05-28 | LEK Pharmaceuticals D.D. | Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0007308D0 (en) * | 2000-03-24 | 2000-05-17 | Pharmacia & Upjohn Spa | Process for preparing crystalline form | of cabergoline |
EP1507777A4 (en) * | 2002-03-15 | 2007-03-07 | Pharmacia Corp | PROCESS FOR THE PREPARATION OF A CRYSTALLINE FORM I OF CABERGOLIN |
AU2003218753A1 (en) * | 2002-03-15 | 2003-09-29 | Pharmacia Corporation | Process for preparing crystalline form i of cabergoline |
CA2525104A1 (en) * | 2003-05-08 | 2004-11-25 | Ivax Pharmaceuticals S.R.O. | Polymorphs of cabergoline |
-
2005
- 2005-07-27 GB GBGB0515430.7A patent/GB0515430D0/en not_active Ceased
-
2006
- 2006-07-27 WO PCT/GB2006/002784 patent/WO2007012846A1/en active Application Filing
- 2006-07-27 AU AU2006273831A patent/AU2006273831A1/en not_active Abandoned
- 2006-07-27 CN CNA200680027137XA patent/CN101228159A/zh active Pending
- 2006-07-27 ZA ZA200801151A patent/ZA200801151B/xx unknown
- 2006-07-27 JP JP2008523446A patent/JP2009502895A/ja not_active Withdrawn
- 2006-07-27 EP EP06765107A patent/EP1912984A1/en not_active Withdrawn
- 2006-07-27 CA CA002616738A patent/CA2616738A1/en not_active Abandoned
-
2008
- 2008-01-06 IL IL188598A patent/IL188598A0/en unknown
- 2008-01-24 NO NO20080461A patent/NO20080461L/no not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170095507A1 (en) * | 2014-08-17 | 2017-04-06 | Shanxi Zhendong Ante Biopharmaceutical Co., Ltd. | Dispersion preparation containing colloidal bismuth pectin and preparing method therefor |
Also Published As
Publication number | Publication date |
---|---|
ZA200801151B (en) | 2009-04-29 |
JP2009502895A (ja) | 2009-01-29 |
AU2006273831A1 (en) | 2007-02-01 |
NO20080461L (no) | 2008-04-18 |
CA2616738A1 (en) | 2007-02-01 |
WO2007012846A1 (en) | 2007-02-01 |
EP1912984A1 (en) | 2008-04-23 |
GB0515430D0 (en) | 2005-08-31 |
IL188598A0 (en) | 2008-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE1012869A3 (fr) | Procede de stabilisation d'un macrolide poly-ene et composition pharmaceutique contenant un tel compose. | |
JP2013100299A (ja) | ラキニモドナトリウムの結晶、及びその製造方法 | |
JP2007535526A (ja) | カベルゴリンの調製 | |
CN101228159A (zh) | 卡麦角林溶剂化物以及卡麦角林ⅰ型的制备 | |
EP3239165A1 (en) | Composition containing nitrogen heterocyclic hexapeptide precursor and preparation method and application thereof | |
CN108774217B (zh) | 一种阿齐沙坦微粉原料药的制备工艺 | |
EP2956439B1 (en) | Process for preparing atazanavir sulphate | |
CN101208337A (zh) | 卡麦角林的制备 | |
RU2277536C2 (ru) | Способ получения кристаллической формы i каберголина, сольват формы х каберголина и способ его получения | |
CN111454255B (zh) | 一种小粒度阿齐沙坦的制备方法 | |
EP0747344A1 (en) | Process for the purification and crystallisation of iopamidol | |
JPH06192228A (ja) | 結晶性(r)−(−)−2−シクロヘプチル−n−メチルスルフオニル−[4−(2−キノリニルメトキシ)−フエニル]−アセトアミド | |
CN1282320A (zh) | (r)-3-[[(4-氟苯基)磺酰基]氨基]-1,2,3,4-四氢-9h-咔唑-9-丙酸(拉马曲班)的热力学稳定形式 | |
CN106432201B (zh) | 一种坎地沙坦酯结晶的制备方法 | |
EP2135869A1 (en) | Preparation of a crystalline form of cabergoline | |
CN113368115B (zh) | 一种罗库溴铵的药物组合物以及罗库溴铵的精制方法 | |
WO2006125453A1 (en) | Process for the preparation of pure crystalline tibolone | |
EP2835377B1 (en) | New crystal form h of ginsenoside c-k and method for preparing same | |
KR20240050699A (ko) | 17알파-에스트라디올의 신규 결정다형 및 이의 제조방법 | |
WO1999052935A1 (fr) | Formes cristallines du 1s-[1alpha (2s*,3r*),9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepine-1- carboxamide | |
EP2835378A1 (en) | Ginsenoside c-k polymorphic compounds and method for preparing same | |
WO2007026372A2 (en) | Novel crystalline polymorph of trandolapril and a process for preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080723 |